CN Patent

CN103338772A — 用于预防或治疗青光眼的药物疗法

Assigned to Kowa Co Ltd · Expires 2013-10-02 · 13y expired

What this patent protects

本发明在于提供一种降眼压作用强且其持续时间延长的用于预防青光眼或者预防或治疗高眼压症的药物疗法。一种用于预防或治疗青光眼的(S)-(-)-1-(4-氟-5-异喹啉磺酰基)-2-甲基-1,4-高哌嗪或其盐或者它们的溶剂化物和前列素类的组合。

USPTO Abstract

本发明在于提供一种降眼压作用强且其持续时间延长的用于预防青光眼或者预防或治疗高眼压症的药物疗法。一种用于预防或治疗青光眼的(S)-(-)-1-(4-氟-5-异喹啉磺酰基)-2-甲基-1,4-高哌嗪或其盐或者它们的溶剂化物和前列素类的组合。

Drugs covered by this patent

Patent Metadata

Patent number
CN103338772A
Jurisdiction
CN
Classification
—
Expires
2013-10-02
Drug substance claim
No
Drug product claim
No
Assignee
Kowa Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.